WESTON, Fla., April 16, 2008 (PRIME NEWSWIRE) -- HealthSport, Inc. (OTCBB:HSPO), a fully integrated developer, manufacturer and marketer of branded nutritional supplements in a one-of-kind edible film strip delivery system, announced today that the Company has raised $660,000 in equity by selling 1,650,000 restricted common shares at a sales price of $.40/share. In addition, the Company issued the shareholders warrants to purchase an additional 330,000 common shares at $.80/share. Over $400,000 of the equity capital raised came from current shareholders of HealthSport, Inc.
"We have received tremendous support from our shareholders, and their investment demonstrates their belief in our technology and the new direction the Company is moving in to generate revenue. I believe all our shareholders will be pleased as the Company moves forward and begins to generate revenues from our newly developed sales strategy," stated Robert Kusher, CEO, HealthSport, Inc.
About HealthSport, Inc.
HealthSport (http://www.healthsportinc.com) is a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional supplements and over-the-counter drugs. The Company owns three subsidiaries - Enlyten, Inc., InnoZen, Inc. and Cooley Nutraceuticals, Inc. Enlyten (http://www.enlytenstrips.com) was created to market and distribute HealthSport's products. InnoZen (http://www.innozen.com) is the preeminent formulator, developer and manufacturer of edible film strips that deliver drug actives through buccal (between cheek and gun) absorption. InnoZen's proprietary edible film strip delivery technology is superior to any other competitive edible film strips currently available on the market. InnoZen has five patents pending and has developed numerous trade secrets which it incorporates in the development and manufacturing process of edible film strips.
Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks, and uncertainties and actual results could differ from those discussed. This material is information only and is not an offer or solicitation to buy or sell the securities.